Anti-PDE4D antibody [EPR11823-29]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal PDE4D antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
DPDE3, PDE4D, PDE43, cAMP-specific phosphodiesterase 4D
- WB
Supplier Data
Western blot - Anti-PDE4D antibody [EPR11823-29] (AB171749)
All lanes:
Anti-cardiac Troponin I antibody (<a href='/en-us/products/unavailable/cardiac-troponin-i-antibody-ab1000'>ab1000</a>) at 1/171749 dilution
Lane 1:
Human fetal heart lysate at 10 µg
Lane 2:
Human fetal brain lysate at 10 µg
Lane 3:
K562 cell lysate at 10 µg
Predicted band size: 91 kDa
false
Related conjugates and formulations (1)
-
Anti-PDE4D antibody [EPR11823-29] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDE4D plays an important role in the modulation of intracellular cAMP levels impacting processes such as inflammation cognition and cardiac function. It does not operate as part of a larger complex but collaborates with other signaling molecules to influence cellular responses. PDE4D's regulation of cAMP levels directly affects protein kinase A (PKA) leading to alterations in gene expression and cell activity.
Pathways
PDE4D integrates into the cAMP signaling and inflammatory pathways impacting various cellular responses. In the cAMP signaling pathway it partners with other PDEs and signaling proteins such as PKA which phosphorylates target proteins affecting cellular function. In inflammatory pathways PDE4D modulates immune cell activity by altering the cAMP-mediated inhibition of pro-inflammatory cytokine production linking it to inflammation-related responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
The FEBS journal 292:3360-3377 PubMed39673076
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 80:178 PubMed37306762
2023
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostics (Basel, Switzerland) 11: PubMed34063765
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com